Pliant Therapeutics has started assembling an expert panel to review unblinded data from its BEACON-IPF Phase 2b trial for a treatment in patients with idiopathic pulmonary fibrosis, following a recommendation from the trial's Data Safety Monitoring
AI Assistant
PLIANT THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.